163 related articles for article (PubMed ID: 27329045)
1. Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.
Korkmaz B; Lesner A; Guarino C; Wysocka M; Kellenberger C; Watier H; Specks U; Gauthier F; Jenne DE
Pharmacol Rev; 2016 Jul; 68(3):603-30. PubMed ID: 27329045
[TBL] [Abstract][Full Text] [Related]
2. Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation.
Gabillet J; Millet A; Pederzoli-Ribeil M; Tacnet-Delorme P; Guillevin L; Mouthon L; Frachet P; Witko-Sarsat V
J Immunol; 2012 Sep; 189(5):2574-83. PubMed ID: 22844112
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.
Grimminger F; Hattar K; Papavassilis C; Temmesfeld B; Csernok E; Gross WL; Seeger W; Sibelius U
J Exp Med; 1996 Oct; 184(4):1567-72. PubMed ID: 8879231
[TBL] [Abstract][Full Text] [Related]
4. New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.
Guarino C; Legowska M; Epinette C; Kellenberger C; Dallet-Choisy S; Sieńczyk M; Gabant G; Cadene M; Zoidakis J; Vlahou A; Wysocka M; Marchand-Adam S; Jenne DE; Lesner A; Gauthier F; Korkmaz B
J Biol Chem; 2014 Nov; 289(46):31777-31791. PubMed ID: 25288799
[TBL] [Abstract][Full Text] [Related]
5. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen.
Jégot G; Derache C; Castella S; Lahouassa H; Pitois E; Jourdan ML; Remold-O'Donnell E; Kellenberger C; Gauthier F; Korkmaz B
FASEB J; 2011 Sep; 25(9):3019-31. PubMed ID: 21670065
[TBL] [Abstract][Full Text] [Related]
6. Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis.
Seren S; Rashed Abouzaid M; Eulenberg-Gustavus C; Hirschfeld J; Nasr Soliman H; Jerke U; N'Guessan K; Dallet-Choisy S; Lesner A; Lauritzen C; Schacher B; Eickholz P; Nagy N; Szell M; Croix C; Viaud-Massuard MC; Al Farraj Aldosari A; Ragunatha S; Ibrahim Mostafa M; Giampieri F; Battino M; Cornillier H; Lorette G; Stephan JL; Goizet C; Pedersen J; Gauthier F; Jenne DE; Marchand-Adam S; Chapple IL; Kettritz R; Korkmaz B
J Biol Chem; 2018 Aug; 293(32):12415-12428. PubMed ID: 29925593
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory genes expression in granulocytes activated by native proteinase-binding fragments of anti-proteinase 3 IgG.
Surmiak M; Kaczor M; Sanak M
J Physiol Pharmacol; 2015 Aug; 66(4):609-15. PubMed ID: 26348085
[TBL] [Abstract][Full Text] [Related]
8. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis.
Millet A; Martin KR; Bonnefoy F; Saas P; Mocek J; Alkan M; Terrier B; Kerstein A; Tamassia N; Satyanarayanan SK; Ariel A; Ribeil JA; Guillevin L; Cassatella MA; Mueller A; Thieblemont N; Lamprecht P; Mouthon L; Perruche S; Witko-Sarsat V
J Clin Invest; 2015 Nov; 125(11):4107-21. PubMed ID: 26436651
[TBL] [Abstract][Full Text] [Related]
9. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
Korkmaz B; Jenne DE; Gauthier F
Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
[TBL] [Abstract][Full Text] [Related]
10. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis.
van Rossum AP; Limburg PC; Kallenberg CG
Ann N Y Acad Sci; 2005 Jun; 1051():1-11. PubMed ID: 16126939
[TBL] [Abstract][Full Text] [Related]
11. Different forms of alpha-1 antitrypsin and neutrophil activation mediated by human anti-PR3 IgG antibodies.
Surmiak M; Sanak M
Pharmacol Rep; 2016 Dec; 68(6):1276-1284. PubMed ID: 27689755
[TBL] [Abstract][Full Text] [Related]
12. Constitutive and induced forms of membrane-bound proteinase 3 interact with antineutrophil cytoplasmic antibodies and promote immune activation of neutrophils.
Carla Guarino ; Seren S; Lemoine R; Hummel AM; Margotin JE; El-Benna J; Hoarau C; Specks U; Jenne DE; Korkmaz B
J Biol Chem; 2023 Apr; 299(4):103072. PubMed ID: 36849007
[TBL] [Abstract][Full Text] [Related]
13. Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.
Korkmaz B; Jaillet J; Jourdan ML; Gauthier A; Gauthier F; Attucci S
J Biol Chem; 2009 Jul; 284(30):19896-902. PubMed ID: 19447886
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).
Korkmaz B; Lesner A; Letast S; Mahdi YK; Jourdan ML; Dallet-Choisy S; Marchand-Adam S; Kellenberger C; Viaud-Massuard MC; Jenne DE; Gauthier F
Semin Immunopathol; 2013 Jul; 35(4):411-21. PubMed ID: 23385856
[TBL] [Abstract][Full Text] [Related]
15. Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis.
Witko-Sarsat V; Reuter N; Mouthon L
Curr Opin Rheumatol; 2010 Jan; 22(1):1-7. PubMed ID: 19881350
[TBL] [Abstract][Full Text] [Related]
16. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
17. Detachment and cytolysis of human endothelial cells by proteinase 3.
Ballieux BE; Hiemstra PS; Klar-Mohamad N; Hagen EC; van Es LA; van der Woude FJ; Daha MR
Eur J Immunol; 1994 Dec; 24(12):3211-5. PubMed ID: 7805749
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies.
Surmiak M; Kaczor M; Sanak M
J Physiol Pharmacol; 2012 Jun; 63(3):249-56. PubMed ID: 22791638
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
20. Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies.
van Rossum AP; Rarok AA; Huitema MG; Fassina G; Limburg PC; Kallenberg CG
J Leukoc Biol; 2004 Dec; 76(6):1162-70. PubMed ID: 15331626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
